产前入院和产后抑郁症状之间的关联
John R Soehl1, Kathryn Anthony2, Chloe N Matovina3
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert School of Medicine at Brown University, Providence, RI (Soehl and Miller).
American journal of obstetrics & gynecology MFM
|October 18, 2024
概括
怀孕期间住院治疗增加了产后抑郁症的风险. 然而,在怀孕期间早期加入协作护理模式似乎可以减轻这种风险,这表明主动心理健康支持的重要性.
科学领域:
- 围产期心理健康问题
- 孕产妇的健康结果
- 合作护理模式的合作护理模式.
背景情况:
- 产后抑郁症 (PPD) 影响了14%的个人,是孕产妇死亡的重要原因.
- 怀孕并发症可能需要住院治疗,但对PPD的影响还未得到充分研究.
- 产前住院对后来的抑郁症状的影响需要进一步调查.
研究的目的:
- 为了确定怀孕期间住院是否与产后抑郁症状有关.
- 评估在怀孕期间合作护理模式的招生是否减轻了这种关联.
- 调查协作护理时间在PPD风险中的作用.
主要方法:
- 一个前性队列研究 (2017-2021) 的个人在协作护理模式的二次分析.
- 主要结局:6周产后:中度严重到严重的PPD症状 (PHQ-9分数≥15)
- 使用双变量,多变量和布雷斯洛日分析来比较基于产前住院和入院时间的结果.
主要成果:
- 在1897人中,有162人 (8.5%) 在产前住院治疗.
- 产前住院最初与较高的PPD率 (12.4%与7.8%,p=.046) 相关,但在多变量分析中,这并不显著.
- 住院治疗与分娩后注册患者 (19.7%与10.6%,p=.015) 的更高的PPD率有关,但与产前注册患者 (5.8%与5.0%,p=.735) 不相关.
结论:
- 产前住院与中度重度至重度产后抑郁症状的风险增加有关.
- 在怀孕期间注册协作护理模型否定了住院和PPD之间的关联.
- 早期参与心理健康支持计划可能会在产前住院后对PPD产生保护作用.
更多相关视频
相关概念视频
Depression: Overview
222
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
222
Depressive Disorders: Etiology
51
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
51
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Theory of Romantic Attachment in Adulthood
43.2K
Attachment is a long-standing connection or bond with others. While Attachment Theory was conceived in developmental psychology to describe infant-caregiver bonding, it's been extended into adulthood to include romantic relationships.
43.2K
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196


